文献速递关节外科

氨甲环酸可改善全膝关节置换术的长期结局

Administration of Tranexamic Acid Improves Long-Term Outcomes in Total Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2020-03-04

这项多中心队列研究纳入23421例全膝关节置换术,比较4423例接受氨甲环酸与18998例未接受者的结局。

要点

  • 氨甲环酸使全膝关节置换术后2年假体周围关节感染风险降低约50%。
  • 氨甲环酸使术后2年翻修手术风险降低,并降低输血率和住院时间。
  • 氨甲环酸未增加肺栓塞、心肌梗死或卒中风险。

核心结论

  • 全膝关节置换术中给予氨甲环酸可降低假体周围关节感染率和总体翻修手术率,且未观察到血栓栓塞事件差异,使用安全并改善结局。

研究设计与样本

  • 多中心队列研究,共纳入23421例全膝关节置换术,其中4423例接受氨甲环酸、18998例未接受。
  • 采用线性混合模型校正年龄、性别、血栓栓塞预防、Charlson合并症指数、手术年份和外科医生后计算调整比值比。
  • 证据等级为III级观察性队列研究。

关键数值与推荐

  • 主要结局为全膝关节置换术后2年内假体周围关节感染。
  • 次要结局包括翻修手术、冲洗清创、输血和住院时间;不良事件包括再入院、深静脉血栓、肺栓塞、心肌梗死或卒中。

临床怎么用

  • 在全膝关节置换术中可考虑使用氨甲环酸以降低假体周围关节感染、翻修手术、输血率和住院时间。
  • 使用氨甲环酸时未观察到肺栓塞、心肌梗死或卒中风险增加,支持其安全性。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Blood transfusion in total knee arthroplasty (TKA) is associated with increased morbidity, including periprosthetic joint infection (PJI). Tranexamic acid (TXA) reduces blood transfusion rates, but there is limited evidence demonstrating improved outcomes in TKA resulting from TXA administration. The objectives of this study are determining whether TXA is associated with decreased rate of PJI, decreased rate of outcomes associated with PJI, and whether there are differences in rates of adverse events. METHODS: A multicenter cohort study comprising 23,421 TKA compared 4423 patients receiving TXA to 18,998 patients not receiving TXA. Primary outcome was PJI within 2 years of TKA. Secondary outcomes included revision surgery, irrigation and debridement, transfusion, and length of stay. Adverse events included readmission, deep vein thrombosis, pulmonary emboli, myocardial infarction, or stroke. Adjusted odds ratios were determined using linear mixed models controlling for age, sex, thromboembolic prophylaxis, Charlson comorbidity index, year of TKA, and surgeon. RESULTS: TXA administration reduced incidence of PJI by approximately 50% (odds ratio [OR], 0.55; P = .03). Additionally, there was decreased incidence of revision surgery at 2 years (OR, 0.66; P = .02). Patients receiving TXA had reductions in transfusion rate (OR, 0.15; P < .0001) and length of stay (P < .0001). There was no difference in the rate of pulmonary emboli (OR, 1.20; P = .39), myocardial infarction (OR, 0.78; P = .55), or stroke (OR, 1.17; P = .77). CONCLUSION: Administration of TXA in TKA resulted in reduced rate of PJI and overall revision surgery. No difference in thromboembolic events were observed. The use of TXA is safe and improves outcomes in TKA. LEVEL OF EVIDENCE: Level III, Observational Cohort Study.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Drain NP, Gobao VC, Bertolini DM, et al. Administration of Tranexamic Acid Improves Long-Term Outcomes in Total Knee Arthroplasty. J Arthroplasty. 2020. PMID: 32209286. doi:10.1016/j.arth.2020.02.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。